Abstract
Polylactic acid (PLA) fillers are widely used for cosmetic volume augmentation. But, no study has evaluated the use of PLA filler in penile augmentation (PA No. 4). We evaluated the efficacy and safety of a newly developed PLA filler for PA during a 18-month follow-up period. A total of 23 healthy adult men were prospectively enrolled between June and November 2012. Penile girth was measured at proximal-, mid- and distal-shaft at baseline, 3, 6, 12 and 18 months following injection. Subjects’ satisfaction was assessed with visual analogue scale (VAS). Adverse events (AEs) were also reported. Mean injected volume was 20 ml. The circumference of proximal-, mid-, and distal-shaft increased by a mean of 2.2±0.2, 2.7±1.0 and 2.7±1.0 cm at 3 months, respectively (each P<0.001). No significant differences were noted in girth circumference between 3 and 18 months post-injection (each P>0.05). VAS score increased from 51.6±14.7 at baseline to 64.8±19.3 and 74.3±14.6 at 3 and 6 months, respectively (each P<0.05). Six cases of mild, transient treatment-emergent AEs were reported in 5 subjects. Serious AEs were not reported. In conclusion, penile injection of a newly developed PLA filler led to significant penile augmentative effects for up to 18 months and was well tolerated without serious AEs.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 8 print issues and online access
$259.00 per year
only $32.38 per issue
Rent or buy this article
Prices vary by article type
from$1.95
to$39.95
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Vardi Y, Gruenwald I . The status of penile enhancement procedures. Curr Opin Urol 2009; 19: 601–605.
Goldberg DJ . Breakthroughs in US dermal fillers for facial soft-tissue augmentation. J Cosmet Laser Ther 2009; 11: 240–247.
Glogau RG . Fillers: from the past to the future. Semin Cutan Med Surg 2012; 31: 78–87.
Funt D, Pavicic T . Dermal fillers in aesthetics: an overview of adverse events and treatment approaches. Clin Cosmet Investig Dermatol 2013; 6: 295–316.
Luebberding S, Alexiades-Armenakas M . Facial volume augmentation in 2014: overview of different filler options. J Drugs Dermatol 2013; 12: 1339–1344.
Lowe NJ . Optimizing poly-L-lactic acid use. J Cosmet Laser Ther 2008; 10: 43–46.
Ezzat WH, Keller GS . The use of poly-L-lactic acid filler in facial aesthetics. Facial Plast Surg 2011; 27: 503–509.
Lee SH, Ko K, Choo MS, Lee WK, Jeong HC, Cho ST et al. The effect and safety of polylactic acid and adipose-derived stromal vascular fraction cell as an injectable bulking agent in urologic field: a 24-week follow-up study. J Biomed Mater Res B Appl Biomater 2015; 103: 440–447.
Kontis TC . Contemporary review of injectable facial fillers. JAMA Facial Plast Surg 2013; 15: 58–64.
Jones DH . Semipermanent and permanent injectable fillers. Dermatol Clin 2009; 27: 433–444.
Yang DY, Lee WK, Kim SC . Tolerability and efficacy of newly developed penile injection of cross-linked dextran and polymethylmethacrylate mixture on penile enhancement: 6 months follow-up. Int J Impot Res 2013; 25: 99–103.
Buck DW 2nd, Alam M, Kim JY . Injectable fillers for facial rejuvenation: a review. J Plast Reconstr Aesthet Surg 2009; 62: 11–18.
Smith KC . Reversible vs. nonreversible fillers in facial aesthetics: concerns and considerations. Dermatol Online J 2008; 14: 3.
Gogolewski S, Jovanovic M, Perren SM, Dillon JG, Hughes MK . Tissue response and in vivo degradation of selected polyhydroxyacids: polylactides (PLA), poly(3-hydroxybutyrate) (PHB), and poly(3-hydroxybutyrate-co-3-hydroxyvalerate) (PHB/VA). J Biomed Mater Res 1993; 27: 1135–1148.
Kwak TI, Oh M, Kim JJ, Moon, du G . The effects of penile girth enhancement using injectable hyaluronic acid gel, a filler. J Sex Med 2011; 8: 3407–3413.
Kim JJ, Kwak TI, Jeon BG, Cheon J, Moon DG . Effects of glans penis augmentation using hyaluronic acid gel for premature ejaculation. Int J Impot Res 2004; 16: 547–551.
Kang DH, Chung JH, Kim YJ, Lee HN, Cho SH, Chang TH et al. Efficacy and safety of penile girth enhancement by autologous fat injection for patients with thin penises. Aesthetic Plast Surg 2012; 36: 813–818.
Panfilov DE . Augmentative phalloplasty. Aesth Plast Surg 2006; 30: 183–197.
Yacobi Y, Tsivian A, Grinberg R, Kessler O . Short-term results of incremental penile girth enhancement using liquid injectable silicone: Words of praise for a change. Asian J Androl 2007; 9: 408–413.
Vardi Y, Harshai Y, Gil T, Gruenwald I . A critical analysis of penile enhancement procedures for patients with normal penile size: surgical techniques, success, and complications. Eur Urol 2008; 54: 1042–1050.
Casavantes L, Lemperle G, Morales P . Penile girth enhancement with polymethylmethacrylate-based soft tissue fillers. J Sex Med 2016; 13: 1414–1422.
Monheit GD, Coleman KM . Hyaluronic acid fillers. Dermatol Ther 2006; 19: 141–150.
Kim JE, Sykes JM . Hyaluronic acid fillers: history and overview. Facial Plast Surg 2011; 27: 523–528.
Hyun MY, Lee Y, No YA, Yoo KH, Kim MN, Hong CK et al. Efficacy and safety of injection with poly-L-lactic acid compared with hyaluronic acid for correction of nasolabial fold: a randomized, evaluator-blinded, comparative study. Clin Exp Dermatol 2015; 40: 129–135.
Kim JH, Lee HJ, Song YS . Treatment of bladder dysfunction using stem cell or tissue engineering technique. Korean J Urol 2014; 55: 228–238.
No YA, Seok J, Hyun MY, Kwon TR, Oh CT, Choi EJ et al. Long-term (24-month) safety evaluation of poly-DL-lactic acid filler injection for the nasolabial fold: a multicenter, open, randomized, evaluator-blind, active-controlled design. Plast Reconstr Surg 2015; 135: 1074e–1075ee.
Rotunda AM, Narins RS . Poly-L-lactic acid: a new dimension in soft tissue augmentation. Dermatol Ther 2006; 19: 151–158.
Moon DG, Kwak TI, Kim JJ . Glans penis augmentation using hyaluronic acid gel as an injectable filler. World J Mens Health 2015; 33: 50–61.
Narins RS . Minimizing adverse events associated with poly-L-lactic acid injection. Dermatol Surg 2008; 34 (Suppl 1): S100–S104.
Acknowledgements
The authors were investigators on a clinical trial sponsored by REGEN Biotech, Inc., Seoul, Republic of Korea.
Disclaimer
This trial was registered in WHO ICTRP (KCT0001827).
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Competing interests
The authors declare no conflict of interest.
Rights and permissions
About this article
Cite this article
Yang, D., Ko, K., Lee, S. et al. Efficacy and safety of a newly developed polylactic acid microsphere as an injectable bulking agent for penile augmentation: 18-months follow-up. Int J Impot Res 29, 136–141 (2017). https://doi.org/10.1038/ijir.2017.10
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/ijir.2017.10
This article is cited by
-
Complications and outcomes following injection of foreign material into the male external genitalia for augmentation: a single-centre experience and systematic review
International Journal of Impotence Research (2023)
-
Penile girth enhancement procedures for aesthetic purposes
International Journal of Impotence Research (2022)
-
Multidisciplinary approach and management of patients who seek medical advice for penile size concerns: a narrative review
International Journal of Impotence Research (2022)
-
Penile girth augmentation by injectable fillers: a comprehensive review of imaging features and inflammatory complications
Abdominal Radiology (2021)
-
Volumentherapie mit Eigenfett und Filler
ästhetische dermatologie & kosmetologie (2019)